VCAM1 and glioma: Recently, an increasing number of clinical data proved that VCAM1 is abnormally expressed in gastric cancer, renal clear cell carcinoma, melanoma, breast cancer, glioma, and other malignant tumors, and is negatively correlated with the prognosis of patients (29).